{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:53:07Z","timestamp":1777636387006,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.07.082","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T08:37:13Z","timestamp":1564562233000},"page":"A184-A193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"S1","title":["Oral cholera vaccine delivery strategy in India: Routine or campaign?\u2014A scoping review"],"prefix":"10.1016","volume":"38","author":[{"given":"Arindam","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushik","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajshankar","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.07.082_b0005","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.PoH-0012-2015","volume":"4","author":"Lippi","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2019.07.082_b0010","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1093\/infdis\/jiy486","article-title":"Partners of the global task force on cholera control. global cholera epidemiology: opportunities to reduce the burden of cholera by 2030","volume":"218","author":"Legros","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0015","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","volume":"379","author":"Jason","year":"2012","journal-title":"Cholera Lancet"},{"key":"10.1016\/j.vaccine.2019.07.082_b0020","first-page":"297","article-title":"Weekly epidemiological record: cholera","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.07.082_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2471\/BLT.09.073460","article-title":"Cholera in India: an analysis of reports, 1997\u20132006","volume":"88","author":"Kanungo","year":"2010","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.07.082_b0035","first-page":"246","article-title":"How endemic is cholera in India?","volume":"135","author":"Sarkar","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2019.07.082_b0040","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1007\/s10661-014-3851-1","article-title":"Seasonal dynamics of Vibrio cholerae and its phages in riverine ecosystem of Gangetic West Bengal: cholera paradigm","volume":"186","author":"Mookerjee","year":"2014","journal-title":"Environ Monit Assess"},{"key":"10.1016\/j.vaccine.2019.07.082_b0045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3201\/eid1903.121156","article-title":"Vibrio cholerae Non-O1, Non-O139 Serogroups and Cholera-like Diarrhea, Kolkata","volume":"19","author":"Dutta","year":"2013","journal-title":"India. Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0050","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01877-18","article-title":"New variant of Vibrio cholerae O139 in Odisha","author":"Pal","year":"2019","journal-title":"India. J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.082_b0055","unstructured":"Global Task Force on Cholera Control. Prevention and control of cholera outbreaks: WHO policy and recommendations. WHO n.d."},{"key":"10.1016\/j.vaccine.2019.07.082_b0060","article-title":"Cholera vaccines: WHO position paper \u2013 August 2017","volume":"34","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.07.082_b0065","doi-asserted-by":"crossref","first-page":"e1145","DOI":"10.1371\/journal.pntd.0001145","article-title":"Meeting cholera\u2019s challenge to haiti and the world: a joint statement on cholera prevention and care","volume":"5","author":"Farmer","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0070","doi-asserted-by":"crossref","first-page":"e1003","DOI":"10.1371\/journal.pntd.0001003","article-title":"The cholera pandemic, still with us after half a century: time to rethink","volume":"5","author":"Ryan","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0075","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0140-6736(10)62243-X","article-title":"Five complementary interventions to slow cholera: Haiti","volume":"376","author":"Ivers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.082_b0080","doi-asserted-by":"crossref","first-page":"e0135676","DOI":"10.1371\/journal.pone.0135676","article-title":"The impact of water, sanitation and hygiene interventions to control cholera: a systematic review","volume":"10","author":"Taylor","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.082_b0085","doi-asserted-by":"crossref","first-page":"11352","DOI":"10.1021\/es301842u","article-title":"Use of household water treatment and safe storage methods in acute emergency response: case study results from Nepal, Indonesia, Kenya, and Haiti","volume":"46","author":"Lantagne","year":"2012","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.vaccine.2019.07.082_b0090","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4269\/ajtmh.14-0331","article-title":"Cholera at the crossroads: the association between endemic cholera and national access to improved water sources and sanitation","volume":"91","author":"Nygren","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.07.082_b0095","unstructured":"Cravioto A. Conclusions of the SAGE Working Group on oral cholera vaccines and proposed recommendations. 2017."},{"key":"10.1016\/j.vaccine.2019.07.082_b0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4103\/0971-5916.187102","article-title":"Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons","volume":"143","author":"Sen","year":"2016","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2019.07.082_b0105","unstructured":"CDC. Cholera- Vibrio cholerae infection n.d."},{"key":"10.1016\/j.vaccine.2019.07.082_b0110","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0115","doi-asserted-by":"crossref","first-page":"e2828","DOI":"10.1371\/journal.pntd.0002828","article-title":"Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti","volume":"8","author":"Charles","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0120","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1016\/j.vaccine.2011.08.108","article-title":"Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age","volume":"29","author":"Saha","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0125","unstructured":"World Health Organization. Principles and considerations for adding a vaccine to a national immunization programme: From decision to implementation and monitoring. Geneva: 2014."},{"key":"10.1016\/j.vaccine.2019.07.082_b0130","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.07.082_b0135","doi-asserted-by":"crossref","first-page":"e0004616","DOI":"10.1371\/journal.pntd.0004616","article-title":"The burden of typhoid and paratyphoid in india: systematic review and meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"10.1016\/j.vaccine.2019.07.082_b0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology","volume":"5","author":"Levac","year":"2010","journal-title":"Implement Sci"},{"key":"10.1016\/j.vaccine.2019.07.082_b0150","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bmj.38636.593461.68","article-title":"Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources","volume":"331","author":"Greenhalgh","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.07.082_b0155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13643-016-0367-5","article-title":"What guidance is available for researchers conducting overviews of reviews of healthcare interventions? A scoping review and qualitative metasummary","volume":"5","author":"Pollock","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.vaccine.2019.07.082_b0160","first-page":"195","article-title":"Measuring protection: efficacy versus effectiveness","volume":"95","author":"Fedson","year":"1998","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2019.07.082_b0165","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0170","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0040336","article-title":"Controlling endemic cholera with oral vaccines","volume":"4","author":"Longini","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.07.082_b0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.vaccine.2015.12.004","article-title":"Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design","volume":"34","author":"Ali","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0180","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4269\/ajtmh.15-0700","article-title":"Effectiveness of oral cholera vaccine in Haiti: 37-Month follow-up","volume":"94","author":"S\u00e9v\u00e8re","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.07.082_b0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.082_b0190","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/368132","article-title":"Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine","volume":"187","author":"Albert","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0195","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2010.12.133","article-title":"Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age","volume":"29","author":"Matsuda","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0200","first-page":"659","article-title":"Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience","volume":"101","author":"Kim","year":"2011","journal-title":"South African Med J"},{"key":"10.1016\/j.vaccine.2019.07.082_b0205","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1312680","article-title":"Use of Vibrio cholerae vaccine in an outbreak in Guinea","volume":"370","author":"Luquero","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.07.082_b0210","article-title":"Vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in india: the Odisha model","author":"Kar","year":"20148","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0215","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.vaccine.2015.03.073","article-title":"Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India","volume":"33","author":"Wierzba","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0220","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0225","doi-asserted-by":"crossref","first-page":"e22971","DOI":"10.1371\/journal.pone.0022971","article-title":"The role of vaccine coverage within social networks in cholera vaccine efficacy","volume":"6","author":"Root","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.082_b0230","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(15)61140-0","article-title":"Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial","volume":"386","author":"Qadri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.082_b0235","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.13-0183","article-title":"Use of oral cholera vaccine in haiti: a rural demonstration project","volume":"89","author":"Ivers","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.07.082_b0240","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4269\/ajtmh.13-0171","article-title":"Cholera vaccination in urban Haiti","volume":"89","author":"Rouzier","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.07.082_b0245","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1073\/pnas.1102149108","article-title":"Vaccination strategies for epidemic cholera in Haiti with implications for the developing world","volume":"108","author":"Chao","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.07.082_b0250","doi-asserted-by":"crossref","first-page":"e1002120","DOI":"10.1371\/journal.pmed.1002120","article-title":"Potential for controlling cholera using a ring vaccination strategy: re-analysis of data from a cluster-randomized clinical trial","volume":"13","author":"Ali","year":"2016","journal-title":"PLOS Med"},{"key":"10.1016\/j.vaccine.2019.07.082_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003343","article-title":"Comparative effectiveness of different strategies of oral cholera vaccination in Bangladesh: a modeling study","volume":"8","author":"Dimitrov","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0260","series-title":"Country investment case study on cholera vaccination: Bangladesh","author":"International Vaccine Institute","year":"2012"},{"key":"10.1016\/j.vaccine.2019.07.082_b0265","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1016\/j.vaccine.2014.05.028","article-title":"Considerations around the introduction of a cholera vaccine in Bangladesh","volume":"32","author":"Nelson","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)33050-7","article-title":"Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales","author":"Lessler","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.082_b0275","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.07.082_b0280","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1016\/j.vaccine.2013.10.021","article-title":"Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh","volume":"31","author":"Khan","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0285","first-page":"343","article-title":"Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera","volume":"76","author":"Murray","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.07.082_b0290","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","article-title":"Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis","volume":"12","author":"Jeuland","year":"2009","journal-title":"Value Heal"},{"key":"10.1016\/j.vaccine.2019.07.082_b0295","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4269\/ajtmh.14-0159","article-title":"Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator","volume":"91","author":"Troeger","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.07.082_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004072","article-title":"Estimation of private household costs to receive free oral cholera vaccine in Odisha, India","volume":"9","author":"Mogasale","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0305","unstructured":"WHO. Oral cholera vaccines in mass immunization campaigns: guidance for planning and use. Geneva: 2010."},{"key":"10.1016\/j.vaccine.2019.07.082_b0310","series-title":"Vibrio cholerae cholera Mol. to Glob. Perspect.","first-page":"321","article-title":"The Latin American epidemic","author":"Tauxe","year":"1994"},{"key":"10.1016\/j.vaccine.2019.07.082_b0315","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3201\/eid1711.110827","article-title":"Lessons learned during public health response to cholera epidemic in Haiti and the Dominican Republic","volume":"17","author":"Tappero","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0320","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1126\/science.274.5295.2025","article-title":"Global climate and infectious disease: the cholera paradigm","volume":"274","author":"Colwell","year":"1996","journal-title":"Science"},{"issue":"46","key":"10.1016\/j.vaccine.2019.07.082_b0325","doi-asserted-by":"crossref","first-page":"17676","DOI":"10.1073\/pnas.0809654105","article-title":"Environmental signatures associated with cholera epidemics","volume":"105","author":"Constantin de Magny","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2019.07.082_b0330","unstructured":"UNICEF. Oral Cholera Vaccine Market & Supply Update. 2016."},{"key":"10.1016\/j.vaccine.2019.07.082_b0335","doi-asserted-by":"crossref","first-page":"e1001867","DOI":"10.1371\/journal.pmed.1001867","article-title":"The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: a modeling study","volume":"12","author":"Azman","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.07.082_b0340","doi-asserted-by":"crossref","first-page":"e41527","DOI":"10.1371\/journal.pone.0041527","article-title":"Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar","volume":"7","author":"Schaetti","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.082_b0345","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/jpgm.JPGM_104_18","article-title":"Measles-rubella vaccination campaign: a trust deficit?","volume":"64","author":"Sreedevi","year":"2018","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.vaccine.2019.07.082_b0350","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4103\/0971-5916.187102","article-title":"Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons","volume":"143","author":"Gupta","year":"2016","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2019.07.082_b0365","first-page":"501","article-title":"Routine immunization: campaign or routine?","volume":"49","author":"Srivastava","year":"2012","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2019.07.082_b0370","first-page":"649","article-title":"Cost-effectiveness of routine and campaign vaccination strategies in Ecuador","volume":"67","author":"Shepard","year":"1989","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.07.082_b0375","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.vaccine.2012.03.063","article-title":"Factors associated with HPV vaccine uptake in teenage girls: a systematic review","volume":"30","author":"Kessels","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0380","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12879-016-1758-x","article-title":"Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh","volume":"16","author":"Uddin","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.082_b0385","unstructured":"Ministry of Heath & Family Welfare. Government of India. Health Ministry launches single vaccine for dual protection against measles and rubella as part of Universal Immunization Programme. Press Inf Bur Minist Heal Fam Welfare, Gov India 2017."},{"key":"10.1016\/j.vaccine.2019.07.082_b0390","unstructured":"Kulkarni T. Measles-rubella vaccine drive: Schools face opposition from parents. The Hindu 2017."},{"key":"10.1016\/j.vaccine.2019.07.082_b0395","unstructured":"MR vaccine drive: Parents of children in govt. schools got short notice? The Hindu 2017."},{"key":"10.1016\/j.vaccine.2019.07.082_b0400","doi-asserted-by":"crossref","first-page":"H59","DOI":"10.1016\/j.vaccine.2013.03.029","article-title":"Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in central and eastern Europe","volume":"31","author":"Poljak","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0405","unstructured":"The World Bank. Net enrolment rate, primary, both sexes (%) n.d."},{"key":"10.1016\/j.vaccine.2019.07.082_b0410","unstructured":"Department of School Education & Literacy. Ministry of Human Resource Development. Government of India. Educational statistics at a glance. Delhi: 2016."},{"key":"10.1016\/j.vaccine.2019.07.082_b0415","unstructured":"Pratham Education Foundation. Annual Status of Education Report 2016. Delhi: 2017."},{"key":"10.1016\/j.vaccine.2019.07.082_b0420","unstructured":"WHO. Addendum to \u201cOral cholera vaccines in mass immunization campaigns. Guidance for planning and use\u201d 1. n.d."},{"key":"10.1016\/j.vaccine.2019.07.082_b0425","unstructured":"CHOLERA\u202f: A continuing challenge to Public Health. vol. 12. 2008."},{"key":"10.1016\/j.vaccine.2019.07.082_b0430","unstructured":"National Vector Borne Disease Control Programme. Directorate General of Health Services. Ministry of Health & Family Welfare. Government of India. National Programme for Prevention and Control of Japanese Encephalitis\/ Acute Encephalitis Syndrome- Operational Guidelines. Delhi: 2014"},{"key":"10.1016\/j.vaccine.2019.07.082_b0435","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.vaccine.2012.09.044","article-title":"Use of measles supplemental immunization activities (SIAs) as a delivery platform for other maternal and child health interventions: opportunities and challenges","volume":"31","author":"Johri","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.082_b0440","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4161\/hv.29199","article-title":"Maximizing protection from use of oral cholera vaccines in developing country settings","volume":"10","author":"Desai","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.07.082_b0445","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.082_b0450","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldv001","article-title":"Strengthening routine immunization systems to improve global vaccination coverage","volume":"113","author":"Sodha","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1016\/j.vaccine.2019.07.082_b0455","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jrsm.1123","article-title":"A scoping review of scoping reviews: advancing the approach and enhancing the consistency","volume":"5","author":"Pham","year":"2014","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.vaccine.2019.07.082_b0460","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2524.2007.00742.x","article-title":"Making informed choices in social care: the importance of accessible information","volume":"16","author":"Baxter","year":"2007","journal-title":"Health Soc Care Community"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:55Z","timestamp":1759401415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19310035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":90,"alternative-id":["S0264410X19310035"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral cholera vaccine delivery strategy in India: Routine or campaign?\u2014A scoping review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}